Armata Pharmaceuticals, Inc. (ARMP) Misses Q1 EPS by 4c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q1 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• Increasing unusual call volume: INDA LODE XIFR FRSH JMKE SYK BRUN MUU NRG LEN VIAV PAR ALM